There is an increasing evidence that Helicobacter pylori may interfere with gastrointestinal metabolism of micronutrients and drugs such as iron, cobalamin, thyroxine and levodopa, with relevant clinical effects. In this review we examine the strength of the causal association and the plausible pathophysiologic mechanisms underlying these adverse effects. © 2008 Bentham Science Publishers Ltd.
Pietroiusti, A., Galante, A., Magrini, A., Bergamaschi, A. (2008). Helicobacter pylori interference with micronutrients and orally administered drugs: A new mechanism explaining its role in extragastric disorders. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 8(2), 135-141 [10.2174/138955708783498177].
Helicobacter pylori interference with micronutrients and orally administered drugs: A new mechanism explaining its role in extragastric disorders
PIETROIUSTI, ANTONIO;GALANTE, ALBERTO;MAGRINI, ANDREA;
2008-01-01
Abstract
There is an increasing evidence that Helicobacter pylori may interfere with gastrointestinal metabolism of micronutrients and drugs such as iron, cobalamin, thyroxine and levodopa, with relevant clinical effects. In this review we examine the strength of the causal association and the plausible pathophysiologic mechanisms underlying these adverse effects. © 2008 Bentham Science Publishers Ltd.| File | Dimensione | Formato | |
|---|---|---|---|
|
Mini Review_2008.pdf
accesso aperto
Dimensione
216.08 kB
Formato
Adobe PDF
|
216.08 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
